Terns Pharmaceuticals Stock News & Updates
[WKN: A2QNWR | Symbol: TERN]
Terns Pharmaceuticals
Analysts' Top 5 Price Targets of February 9, 2026
Terns Pharmaceuticals: How to Shake Up the Leukemia Market with the Drug TERN-701
Terns Pharmaceuticals is a biopharmaceutical company in the clinical development phase. After exiting...
Analysts' Top 5 Price Targets of November 4, 2025
Terns Pharmaceuticals [US8808811074] Jefferies maintains Buy rating and raises the price target...
Terns Pharmaceuticals: Truist sees enormous market potential and an attractive risk-reward profile for the pipeline!
Currently, one of the standout names on the analysts' Top-10 price target list is Terns Pharmaceuticals...
TOP-5 Price Targets of Analysts on October 15, 2025
Globalstar [US3789735079] Clear Street initiates coverage with "Buy" and a price target of $66 (52%...
Analysts' Top 5 Price Targets of September 17, 2025
Workday [US98138H1014] Jefferies maintains Buy rating with a price target of $325 (40% upside...
- ‹
- 1
- ›